Financials
Financial year 2025
Dr. R. Tavernier, Cardiologie from Zwalm, company number BE0554832674, closed financial year 2025 with a result of € 667,700 after tax. For that financial year Dr. R. Tavernier, Cardiologie recorded a gross margin of € 881,713 and equity of € 686,300. Compared with financial year 2024, the result moved from € 588,271 to € 667,700. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 21, 2026.
€ 686,300
▲ € 667,700 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 667,700
▲ 14% vs 2024
Profit after tax over the fiscal year.
€ 250,148
▼ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 667,700.
People and assets in 2025
€ 13,787
▲ 8% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 30,321
Loans from banks and other lenders, long and short.
€ 1,048
▼ 41% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 55,672
▼ 37% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 811,696 | € 792,925 | € 782,900 | € 881,713 | ▲ 13% |
| Profit after taxes | € 535,165 | € 499,212 | € 588,271 | € 667,700 | ▲ 14% |
| Equity | € 127,863 | € 627,075 | € 18,600 | € 686,300 | ▲ € 667,700 |
| Total debts | € 1,124,808 | € 588,304 | € 639,925 | € 120,007 | ▼ 81% |
| Cash | € 351,105 | € 284,307 | € 341,050 | € 250,148 | ▼ 27% |
| Retained profit | € 109,263 | € 608,475 | € 0 | € 667,700 | |
| Dividend | € 1,050,295 | € 0 | € 1,196,746 | € 0 | ▼ 100% |
| Bank debt | € 30,050 | € 30,706 | € 30,449 | € 30,321 | |
| Balance sheet total | € 1,252,671 | € 1,215,380 | € 658,525 | € 806,307 | ▲ 22% |
Key figures of Dr. R. Tavernier, Cardiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. R. Tavernier, Cardiologie?
What happened at Dr. R. Tavernier, Cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 667,700 (▲ 14% vs 2024). Source: NBB ↗
- New establishment in Brugge. KBO
- Start of the company according to the CBE. KBO
- René Tavernier became a director. NBB
In short
From € 535,165 profit in 2022 to € 667,700 profit in 2025.
Paid € 729,610 in corporate taxes since 2022.
Best year ever: 2025, with € 667,700 profit.
Paid out € 2.2 million in dividends to the owners in total.
Management
Behind Dr. R. Tavernier, Cardiologie is René Tavernier.
Directors
According to the 2025 annual accounts
René Tavernier
Director
since 2014
Establishments
Establishment units
Physical locations of this company
Paulatemstraat(Paul) 45
9630 Zwalm
Spaanse loskaai 1
8000 Brugge
Active since 27 June 2014
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0554.832.674
- VAT number
- BE 0554.832.674
- Registered office
- Paulatemstraat(Paul) 45, 9630 Zwalm
- Names & denominations
- Dr. R. Tavernier, Cardiologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 June 2014
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Activiteiten van medisch specialisten
Overige dienstverlenende activiteiten op het gebied van informatie
Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.